Page last updated: 2024-12-06

propildazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

propildazine: RN given refers to parent cpd; synonym ISF 2123 refers to di-HCl; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68829
CHEMBL ID2107172
CHEBI ID134858
SCHEMBL ID309115
MeSH IDM0055145

Synonyms (30)

Synonym
3-hydrazino-6-((2-hydroxypropyl)methylamino)pyridazine dihydrochloride
ccris 5384
3(2h)-pyridazinone, 6-((2-hydroxypropyl)methylamino)-, hydrazone
pildralazine [inn]
(+-)-1-((6-hydrazino-3-pyridazinyl)methylamino)-2-propanol
brn 0649354
pildralazina [spanish]
pildralazinum [latin]
pildralazine
propildazine
propyldazine
CHEBI:134858
1-[(6-hydrazinylpyridazin-3-yl)-methylamino]propan-2-ol
AKOS006273428
CHEMBL2107172
64000-73-3
unii-fu2bgc781u
5-25-18-00060 (beilstein handbook reference)
pildralazina
pildralazinum
fu2bgc781u ,
SCHEMBL309115
(+/-)-1-((6-hydrazino-3-pyridazinyl)methylamino)-2-propanol
pildralazine [mi]
DTXSID7043746
3-hydrazino-6-[(2-hydroxypropyl)-methylamino]-pyridazin
Q7193849
CS-0025881
HY-106471
1-((6-hydrazinylpyridazin-3-yl)(methyl)amino)propan-2-ol

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"42 mg/kg) on heart rate, arterial blood pressure and plasma renin activity (PRA) was compared with the effect of the substance after treatment at the same respective dosage twice daily over 4 days."( Altered blood pressure response to propyldazine after repeated oral administration in conscious normotensive dogs: role of the renin-angiotensin system.
Bacher, S; Beck, A; Kraupp, O; Raberger, G; Seitelberger, R,
)
0.13
" Pyd action is modified only by the most active purine 2-Cl-adenosine, which displaces the dose-response curves to the right."( Interactions between hydralazine, propildazine and purines on arterial smooth muscle.
Chevillard, C; Saiag, B; Worcel, M, 1981
)
0.54
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
tertiary amino compoundA compound formally derived from ammonia by replacing three hydrogen atoms by organyl groups.
dialkylarylamine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (85.71)18.7374
1990's1 (7.14)18.2507
2000's1 (7.14)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.38 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]